ArtiQ is a young, dynamic and innovative spin-off company of the University of Leuven (Belgium). The company was founded early 2019 by four committed founders with an extensive history in respiratory medicine, medical devices, and artificial intelligence. Working in a range of multidisciplinary fields, the founders identified the opportunity and value that novel technologies could bring to all parties in the respiratory world: patients, doctors, healthcare systems, and the industry.

ArtiQ aims to become the trusted partner of medical practitioners for the diagnosis, treatment, and follow-up of respiratory problems. With our first artificial intelligence-based medical software, ArtiQ.PFT, we are already supporting the interpretation of pulmonary function tests and improving the lung disease diagnostic environment.